BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 29775652)

  • 1. Advances and prospects of Bacillus subtilis cellular factories: From rational design to industrial applications.
    Gu Y; Xu X; Wu Y; Niu T; Liu Y; Li J; Du G; Liu L
    Metab Eng; 2018 Nov; 50():109-121. PubMed ID: 29775652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Biology Toolbox and Chassis Development in Bacillus subtilis.
    Liu Y; Liu L; Li J; Du G; Chen J
    Trends Biotechnol; 2019 May; 37(5):548-562. PubMed ID: 30446263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of proteins and commodity chemicals using engineered Bacillus subtilis platform strain.
    Zhang Q; Wu Y; Gong M; Zhang H; Liu Y; Lv X; Li J; Du G; Liu L
    Essays Biochem; 2021 Jul; 65(2):173-185. PubMed ID: 34028523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances and prospects of
    Luo Z; Yan Y; Du S; Zhu Y; Pan F; Wang R; Xu Z; Xu X; Li S; Xu H
    Crit Rev Biotechnol; 2023 Dec; 43(7):1073-1091. PubMed ID: 35997331
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic engineering and synthetic biology employing Lactococcus lactis and Bacillus subtilis cell factories.
    van Tilburg AY; Cao H; van der Meulen SB; Solopova A; Kuipers OP
    Curr Opin Biotechnol; 2019 Oct; 59():1-7. PubMed ID: 30784872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in systems and synthetic biology approaches for developing novel cell-factories in non-conventional yeasts.
    Patra P; Das M; Kundu P; Ghosh A
    Biotechnol Adv; 2021; 47():107695. PubMed ID: 33465474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial Routes to (2R,3R)-2,3-Butanediol: Recent Advances and Future Prospects.
    Xie NZ; Chen XR; Wang QY; Chen D; Du QS; Zhou GP; Huang RB
    Curr Top Med Chem; 2017; 17(21):2433-2439. PubMed ID: 28474550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Robustness of Microbial Cell Factories.
    Gong Z; Nielsen J; Zhou YJ
    Biotechnol J; 2017 Oct; 12(10):. PubMed ID: 28857502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploitation of Bacillus subtilis as a robust workhorse for production of heterologous proteins and beyond.
    Cui W; Han L; Suo F; Liu Z; Zhou L; Zhou Z
    World J Microbiol Biotechnol; 2018 Sep; 34(10):145. PubMed ID: 30203131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic engineering of Bacillus subtilis fueled by systems biology: Recent advances and future directions.
    Liu Y; Li J; Du G; Chen J; Liu L
    Biotechnol Adv; 2017; 35(1):20-30. PubMed ID: 27867004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modular pathway engineering of Bacillus subtilis for improved N-acetylglucosamine production.
    Liu Y; Zhu Y; Li J; Shin HD; Chen RR; Du G; Liu L; Chen J
    Metab Eng; 2014 May; 23():42-52. PubMed ID: 24560814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus subtilis and Escherichia coli essential genes and minimal cell factories after one decade of genome engineering.
    Juhas M; Reuß DR; Zhu B; Commichau FM
    Microbiology (Reading); 2014 Nov; 160(Pt 11):2341-2351. PubMed ID: 25092907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic redesign of central carbon and redox metabolism for high yield production of N-acetylglucosamine in Bacillus subtilis.
    Gu Y; Lv X; Liu Y; Li J; Du G; Chen J; Rodrigo LA; Liu L
    Metab Eng; 2019 Jan; 51():59-69. PubMed ID: 30343048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacillus subtilis: a universal cell factory for industry, agriculture, biomaterials and medicine.
    Su Y; Liu C; Fang H; Zhang D
    Microb Cell Fact; 2020 Sep; 19(1):173. PubMed ID: 32883293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic engineering of Bacillus subtilis for l-valine overproduction.
    Westbrook AW; Ren X; Moo-Young M; Chou CP
    Biotechnol Bioeng; 2018 Nov; 115(11):2778-2792. PubMed ID: 29981237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward metabolic engineering in the context of system biology and synthetic biology: advances and prospects.
    Liu Y; Shin HD; Li J; Liu L
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1109-18. PubMed ID: 25547833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic biology: UBER - a portable system for cross-species genetic engineering.
    Osório J
    Nat Rev Genet; 2015 Sep; 16(9):500. PubMed ID: 26260260
    [No Abstract]   [Full Text] [Related]  

  • 18. Promoter Screening from Bacillus subtilis in Various Conditions Hunting for Synthetic Biology and Industrial Applications.
    Song Y; Nikoloff JM; Fu G; Chen J; Li Q; Xie N; Zheng P; Sun J; Zhang D
    PLoS One; 2016; 11(7):e0158447. PubMed ID: 27380260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positioning Bacillus subtilis as terpenoid cell factory.
    Pramastya H; Song Y; Elfahmi EY; Sukrasno S; Quax WJ
    J Appl Microbiol; 2021 Jun; 130(6):1839-1856. PubMed ID: 33098223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards semi-synthetic microbial communities: enhancing soy sauce fermentation properties in B. subtilis co-cultures.
    Det-Udom R; Gilbert C; Liu L; Prakitchaiwattana C; Ellis T; Ledesma-Amaro R
    Microb Cell Fact; 2019 Jun; 18(1):101. PubMed ID: 31159886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.